Re: Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial
ESMO Open, cilt.10, sa.9, 2025 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Kısa Makale
- Cilt numarası: 10 Sayı: 9
- Basım Tarihi: 2025
- Doi Numarası: 10.1016/j.esmoop.2025.105765
- Dergi Adı: ESMO Open
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
- Ankara Üniversitesi Adresli: Evet